Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy

BACKGROUND: As neoadjuvant chemotherapy (NAC) is increasingly used in triple-negative breast cancer (TNBC), we investigated the value of circulating tumor DNA (ctDNA) for patient monitoring prior, during, and after NAC, and circulating tumor cells (CTCs) for disease characterization at clinical prog...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:ESMO Open
Päätekijät: Ortolan, E., Appierto, V., Silvestri, M., Miceli, R., Veneroni, S., Folli, S., Pruneri, G., Vingiani, A., Belfiore, A., Cappelletti, V., Vismara, M., Dell'Angelo, F., De Cecco, L., Bianchi, G.V., de Braud, F.G., Daidone, M.G., Di Cosimo, S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2021
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8010400/
https://ncbi.nlm.nih.gov/pubmed/33743331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2021.100086
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia